LSE - Delayed Quote GBp
Scancell Holdings plc (SCLP.L)
At close: November 7 at 2:45 PM GMT
Breakdown
TTM
4/30/2024
4/30/2023
4/30/2022
4/30/2021
Operating Cash Flow
-15,660.00
-15,660.00
-8,140.00
-10,193.00
-7,803.00
Investing Cash Flow
178.00
178.00
81.00
-1,264.00
-741.00
Financing Cash Flow
10,390.00
10,390.00
-746.00
-928.00
46,079.00
End Cash Position
14,817.00
14,817.00
19,920.00
28,725.00
41,110.00
Capital Expenditure
-177.00
-177.00
-203.00
-1,268.00
-744.00
Issuance of Capital Stock
11,989.00
11,989.00
166.00
--
24,136.00
Issuance of Debt
--
--
--
--
23,901.00
Free Cash Flow
-15,837.00
-15,837.00
-8,343.00
-11,461.00
-8,547.00
4/30/2021 - 2/12/2010
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
OXB.L Oxford Biomedica plc
417.00
+0.36%
ULTI.OL Ultimovacs ASA
1.8500
0.00%
NYKD.OL Nykode Therapeutics AS
4.2920
+0.42%
SNG.L Synairgen plc
4.8500
+6.36%
FARON.HE Faron Pharmaceuticals Oy
1.9200
+6.90%
ORGS Orgenesis Inc.
1.1800
-1.67%
AVCT.L Avacta Group Plc
50.00
+3.20%
ONT.L Oxford Nanopore Technologies plc
133.10
+1.29%
DTIL Precision BioSciences, Inc.
8.42
+0.24%
BAVA.CO Bavarian Nordic A/S
204.00
+2.00%